July 3, 2023, 1 p.m. | Kristin Houser

Freethink www.freethink.com

AI-driven drug development has led to the launch of phase 2 trials of a drug to treat idiopathic pulmonary fibrosis (IPF).

ai development disease drug development health launch medicine

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US